|Min SIP Amount||Not Supported|
|NAV||₹7.00 (07 Aug 2020)|
|Fund Started||12 Mar 2018|
|Fund Size||₹418 Cr|
|Nath Bio Genes (India) Ltd.||FMCG||Equity||5.7%|
|Colgate-Palmolive (India) Ltd.||FMCG||Equity||5.3%|
|Pidilite Industries Ltd.||Chemicals||Equity||5.2%|
|Whirlpool Of India Ltd.||Cons Durable||Equity||4.0%|
|Bata India Ltd.||FMCG||Equity||3.8%|
|Cadila Healthcare Ltd.||Healthcare||Equity||3.8%|
|Finolex Industries Ltd.||Chemicals||Equity||3.6%|
Aditya Birla Sun Life Resurgent India Fund Series 6 Regular Growth is a Equity Mutual Fund Scheme launched by Aditya Birla Sun Life Mutual Fund. This scheme was made available to investors on 12 Mar 2018. Satyabrata Mohanty, Milind Bafna is the Current Fund Manager of Aditya Birla Sun Life Resurgent India Fund Series 6 Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹418 Cr and the Latest NAV as of 07 Aug 2020 is ₹7.00.
The Aditya Birla Sun Life Resurgent India Fund Series 6 Regular Growth is rated Moderately High risk. Minimum SIP Investment is set to 500.
The investment objective of the scheme is to provide capital appreciation by investing primarily in equity and equity related securities that are likely to benefit from recovery in the Indian economy.The Scheme does not guarantee or indicate any returns. There can be no assurance that the schemes objectives will be achieved.